34 parallel-and-distributed-computing-phd PhD positions at University of Cambridge in United Kingdom
Sort by
Refine Your Search
-
Research Infrastructure? No Offer Description Two fully-funded 3-year PhD studentships are available in Neuromorphic and Bio-inspired computing at the interface between control engineering, electrical
-
application of computational tools for the early detection and deconstruction of chromosomal instability in cancer” For further information about the research group, including their most recent publications
-
Two fully-funded 3-year PhD studentships are available in Neuromorphic and Bio-inspired computing at the interface between control engineering, electrical engineering, computational neuroscience
-
Science and Technology (CST) at the University of Cambridge. The goal of this PhD programme is to launch one "deceptive by design" project that combines the perspectives of human-computer interaction (HCI) and
-
The Centre for Doctoral Training in Nanoscience and Nanotechnology (NanoDTC) at the University of Cambridge invites applications for its 3.5-year interdisciplinary PhD programme. The programme
-
CAM-Doctoral Training Partnership is offering opportunities for ESRC-funded PhD studentships at Anglia Ruskin University, the University of Bedfordshire and the University of Cambridge starting in
-
Location: Central Cambridge Applications are invited for a fully funded 4-year PhD studentship based in the Department of Biochemistry, University of Cambridge, and the new AstraZeneca Discovery
-
non-clinical PhD studentship in cardiometabolic research, commencing October 2026 in the Department of Medicine (VPD Heart & Lung Research Institute), University of Cambridge. The project will be based
-
PhD studentship: Defining the role of the pioneer factor FOXA1 in hormone-dependent cancer Supervisor: Professor Jason Carroll Course start date: 1st October 2026 Project details For further
-
Supervisors: Dr Tim Halim and Dr Gregory Hamm Course start: 1st October 2026 Overview The project will be supervised by Dr Tim Halim, Dr Albert Koulman (Institute of Metabolic Science) and Dr Gregory Hamm (AstraZeneca). Project details The tumour immunity cycle involves cyclical trafficking of...